Erratum: Impact of Lean Body Mass-Based Oxaliplatin Dose Calculation on Neurotoxicity in Adjuvant Treatment of Stage III Colon Cancer: Results of the Phase II Randomized LEANOX Trial

Eric Assenat; Meher Ben Abdelghani; Sophie Gourgou; Hervé Perrier; Faiza Khemissa Akouz; Romain Desgrippes; Marie-Pierre Galais; Chloé Janiszewski; Thibault Mazard; Yves Rinaldi; Côme Lepage; Raphael Tetreau; Pierre Senesse

doi:10.1200/JCO-25-02239

Retour

Erratum: Impact of Lean Body Mass-Based Oxaliplatin Dose Calculation on Neurotoxicity in Adjuvant Treatment of Stage III Colon Cancer: Results of the Phase II Randomized LEANOX Trial

Article de revue

Avec comité de lecture

Erratum: Impact of Lean Body Mass-Based Oxaliplatin Dose Calculation on Neurotoxicity in Adjuvant Treatment of Stage III Colon Cancer: Results of the Phase II Randomized LEANOX Trial

Eric Assenat, Meher Ben Abdelghani, Sophie Gourgou, Hervé Perrier, Faiza Khemissa Akouz, Romain Desgrippes, Marie-Pierre Galais, Chloé Janiszewski, Thibault Mazard, Yves Rinaldi, …

Journal of clinical oncology, Vol.43(35), pp.3774-3774

10/12/2025

DOI: https://doi.org/10.1200/JCO-25-02239

PMID: 41150998

Indicateurs

1 Consultations de la notice

Détails

Titre: Erratum: Impact of Lean Body Mass-Based Oxaliplatin Dose Calculation on Neurotoxicity in Adjuvant Treatment of Stage III Colon Cancer: Results of the Phase II Randomized LEANOX Trial
Créateurs - sans rôle: Eric Assenat
Meher Ben Abdelghani
Sophie Gourgou
Hervé Perrier
Faiza Khemissa Akouz
Romain Desgrippes
Marie-Pierre Galais
Chloé Janiszewski
Thibault Mazard
Yves Rinaldi
Côme Lepage
Raphael Tetreau
Pierre Senesse
Détails de publication: Journal of clinical oncology, Vol.43(35), pp.3774-3774
Identifiants: 99139650109311
Unité académique: Institut de Recherche en Cancérologie de Montpellier - IRCM; Institut de Génétique Moléculaire de Montpellier - IGMM
Langue: English
Type de ressource: Journal article